Statistics for Designing new kinase inhibitor derivatives as therapeutics against common complex diseases : structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition
Total visits
views | |
---|---|
Designing new kinase inhibitor derivatives as therapeutics against common complex diseases : structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition | 571 |
Total visits per month
views | |
---|---|
May 2024 | 10 |
June 2024 | 6 |
July 2024 | 9 |
August 2024 | 10 |
September 2024 | 11 |
October 2024 | 6 |
November 2024 | 0 |
File Visits
views | |
---|---|
Naz_OMICS-JIB_Vol19No11_2015.pdf(legacy) | 222 |
Top country views
views | |
---|---|
Germany | 70 |
China | 37 |
United States | 31 |
South Africa | 24 |
France | 18 |
Japan | 9 |
Finland | 7 |
Netherlands | 5 |
Ireland | 4 |
Hong Kong SAR China | 3 |
United Kingdom | 2 |
Austria | 1 |
Canada | 1 |
Italy | 1 |
Russia | 1 |
Vietnam | 1 |
Top city views
views | |
---|---|
Mountain View | 14 |
Durban | 8 |
Johannesburg | 6 |
Des Moines | 4 |
Dublin | 4 |
Ashburn | 3 |
Shanghai | 3 |
Beijing | 2 |
Buffalo | 2 |
Fuzhou | 2 |
Putian | 2 |
Roubaix | 2 |
Tokyo | 2 |
Amsterdam | 1 |
Clifton | 1 |
Columbus | 1 |
Frankfurt am Main | 1 |
Hanoi | 1 |
Las Vegas | 1 |
Leers | 1 |
Los Angeles | 1 |
Montréal | 1 |
Pisa | 1 |
Shenzhen | 1 |
Tianjin | 1 |
Watertown | 1 |
Zhengzhou | 1 |